Valneva SE (VALN) Cash from Operations (2021 - 2026)

Valneva SE's (VALN) quarterly Cash from Operations came in at 365272.64 in Q1 2026, up 95.51% year-on-year from 186829.55 in Q1 2025, and up 98.71% quarter-over-quarter from 28372396.63 in Q4 2025.

Valneva SE (VALN) Cash from Operations (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Cash from Operations across 6 years of filings, most recently posting 365272.64 for Q1 2026.

  • Cash from Operations for Q1 2026 came in at 365272.64, up 95.51% year-over-year; the trailing twelve-month figure through Mar 2026 was 50362209.73 (changed 0.07% YoY), and the FY2025 annual result was 59006529.8, up 17.85% from the prior year.
  • Cash from Operations came in at 365272.64 for Q1 2026 at Valneva SE, up from 28372396.63 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 71079696976.12 in Q3 2023 to a low of 71224011635.87 in Q2 2023.
  • The 5-year median for Cash from Operations is 28372396.63 (2025), against an average of 36863032.15.
  • Peak annual rise in Cash from Operations reached 79290.74% in 2023, while the deepest fall reached 91891.49% in 2023.
  • Valneva SE's Cash from Operations stood at 57907199.96 in 2022, then retreated by 20.17% to 69587489.55 in 2023, then jumped by 112.24% to 8514568.15 in 2024, then slumped by 433.22% to 28372396.63 in 2025, then surged by 98.71% to 365272.64 in 2026.
  • The last three Cash from Operations figures came in at 365272.64 (Q1 2026), 28372396.63 (Q4 2025), and 18644090.6 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -1.67 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -12.20 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -2.49 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 1.43 Bn
9 Abivax 94.26 Bn 94.26 Bn - -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn -365,272.64

Historic Data

Download Data
DateValue
Mar 31, 2026 -365,272.64
Mar 31, 2026 -365,272.64
Dec 31, 2025 -28.37 Mn
Dec 31, 2025 -28.37 Mn
Sep 30, 2025 -18.64 Mn
Sep 30, 2025 -18.64 Mn
Jun 30, 2025 -2.98 Mn
Jun 30, 2025 -2.98 Mn
Mar 31, 2025 -8.14 Mn
Mar 31, 2025 -8.14 Mn
Dec 31, 2024 8.51 Mn
Dec 31, 2024 8.51 Mn
Sep 30, 2024 -11.02 Mn
Sep 30, 2024 -11.02 Mn
Jun 30, 2024 -39.68 Mn
Jun 30, 2024 -39.68 Mn
Mar 31, 2024 -30.75 Mn
Mar 31, 2024 -30.75 Mn
Dec 31, 2023 -69.59 Mn
Dec 31, 2023 -69.59 Mn